Switzerland As home to much of Europe’s innovative medicine output and as one of its wealthiest nations per capita, Switzerland has not traditionally been a generic-friendly market. Generics prices are relatively high in a European context and only accounted for 14 percent of total drug sales in 2022. Nevertheless, in recent…
Switzerland iQone Healthcare has achieved impressive growth under the leadership of CEO Michele Genini, who has guided the company from launching a single biosimilar product in 2016 to building a diverse portfolio of seven. Now part of Celltrion and with a strategic focus on the Swiss market, iQone has become a…
Switzerland Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to base the company in Switzerland, its partnership deal with Korean biosimilar giant Celltrion, and where iQone’s future lies. For me, Switzerland is one of the best places in Europe to start a business Having previously…
See our Cookie Privacy Policy Here
